Literature DB >> 2008800

Humoral immunity against tick-borne encephalitis virus following manifest disease and active immunization.

U Klockmann1, H L Bock, H Kwasny, M Praus, V Cihlová, E Tomková, K Krivanec.   

Abstract

Humoral immunity against tick-borne encephalitis virus (TBEV) in patients with a well-documented history of naturally acquired tick-borne encephalitis (TBE) was compared with immunity resulting from vaccination in a carefully controlled immunization programme. The vaccination study was performed with a highly purified, inactivated virus particle vaccine and the immune response was followed by tracing the course of IgG antibody formation in an enzyme-linked immunosorbent assay and a neutralization assay. It was shown that this TBE vaccine induced a strong immune response. TBE IgG antibody titres measured after three vaccinations were of the same order of magnitude as those determined in patients recovered from manifest TBE.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2008800     DOI: 10.1016/0264-410x(91)90315-w

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  4 in total

1.  Cost-benefit analysis of vaccination against tick-borne encephalitis among French troops.

Authors:  Guillaume Desjeux; Laurent Galoisy-Guibal; Cyrille Colin
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

2.  Tick-borne encephalitis virus-neutralizing antibodies in different immunoglobulin preparations.

Authors:  Philip O Rabel; Christina B Planitzer; Maria R Farcet; Thomas R Kreil
Journal:  Clin Vaccine Immunol       Date:  2012-02-29

Review 3.  History of Arbovirus Research in the Czech Republic.

Authors:  Zdenek Hubálek
Journal:  Viruses       Date:  2021-11-22       Impact factor: 5.048

4.  Predicted long-term antibody persistence for a tick-borne encephalitis vaccine: results from a modeling study beyond 10 years after a booster dose following different primary vaccination schedules.

Authors:  Marco Costantini; Andrea Callegaro; Jiří Beran; Valérie Berlaimont; Ilaria Galgani
Journal:  Hum Vaccin Immunother       Date:  2020-01-17       Impact factor: 3.452

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.